Araceli Biosciences Launches High Content Analytics Platform Endeavor
Araceli Biosciences, provider of advanced biological imaging platforms, today announced the launch of its flagship product, the Araceli EndeavorMT. Endeavor is revolutionizing drug discovery by offering high speed, high resolution and comprehensive scanning of cellular assays.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210125005277/en/
Endeavor images 10 times the biology in a fraction of the time, acquiring every cell, every time. Endeavor combines exceptionally fast and comprehensive imaging with a pixel resolution of less than half a micron, generating high-quality, high-resolution data.
With no training required, the Araceli platform makes high content analysis comprehensive, fast and easy. With smart tools, users can generate quality results quickly and with confidence, reducing the time required for drug discovery. A single Endeavor system can acquire over 20,000 complete wells per day, at a peak rate of 480 megapixels / second.
Jeff Harris, Managing Director of Araceli Biosciences, said: “The role of high content analysis in drug discovery has unfortunately been limited over the past 20 years due to throughput. It just hasn’t been fast enough. We decided to change that. “
Maggie Vantangoli Policelli, PhD, Product Manager at Araceli Biosciences, said: “We are very excited to launch Endeavor and to meet a huge need in drug discovery. Now Endeavor quickly collects ultra-high resolution data from every cell. It’s a game-changer: With high-resolution full-well imaging, you can see more biology than ever before, faster than ever.
Endeavor will be showcased this year at the Society for Laboratory Automation and Screening Virtual Conference January 25-28, 2021. Come visit us to see it in action!
About Araceli Biosciences
Araceli Biosciences provides high performance scientific tools for the discovery of tissue and cell based biomarkers and drugs. With decades of combined experience in biomedical research and instrument design, we are focused on developing scientific instruments to improve outcomes and enable our clients to advance scientific and medical research. We believe in reducing the time it takes to acquire high quality data and achieve clear, high quality results. By making cutting-edge technologies accessible, we allow researchers to focus on the science, not the tool. We develop innovative products that accelerate basic research, drug discovery and manufacturing. We believe in blurring the line between science and technology, using one to improve the other in a holistic approach.
View the source version on businesswire.com: https://www.businesswire.com/news/home/20210125005277/en/
Maggie Vantangoli Policelli